HHS HHS Proposed Automatic Sunset Rule Thomas Sullivan Dec 1, 2020 0 The Department of Health and Human Services (HHS) recently issued a proposed rule to undertake a retrospective review of older…
FDA FDA Draft Guidance on Postmarking Reporting Thomas Sullivan Nov 30, 2020 0 The FDA issued a draft guidance regarding its postmarketing requirements (PMRs) and commitments. The document details how drug and…
Anti Kickback HHS OIG Releases Final Rule Amending AKS Discount Safe Harbor Thomas Sullivan Nov 25, 2020 0 On November 20, 2020, the United States Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued a…
ACCME ACCME 2021 Meeting – Call for Proposals Thomas Sullivan Nov 24, 2020 0 The Accreditation Council for Continuing Medical Education (ACCME) has opened the Call for Proposals for its 2021 Meeting, which…
CMS Trump Administration Issues Most Favored Nation Model Thomas Sullivan Nov 23, 2020 0 On Friday, November 20, 2020, United States President Donald Trump and the Centers for Medicare and Medicaid Services (CMS)…
MedPAC MedPAC Discusses the Future of Telehealth and Medicare Thomas Sullivan Nov 20, 2020 0 In a virtual public meeting earlier this year, the Medicare Payment Advisory Commission (MedPAC) discussed a potential permanent…
CME MedPAC Discusses Revising Medicare IME Policies Thomas Sullivan Nov 19, 2020 0 During its September 2019 public meeting, the Medicare Payment Advisory Commission (MedPAC) discussed revising the current…
Open Payments JAMA Research Letter Finds the Share of Physicians Receiving Industry… Thomas Sullivan Nov 18, 2020 0 A recent research letter published in JAMA stated that since the 2014 launch of the Open Payments database, the share of…
Anti Kickback HHS OIG Issues Special Fraud Alert: Focused on Promotional Speakers… Thomas Sullivan Nov 17, 2020 0 The United States Department of Health and Human Services Office of Inspector General (HHS-OIG) issued a “Special Fraud Alert:…
COVID-19 FDA Temporary Guidance Outlines Path for Manufacturing to Return to Normal Thomas Sullivan Nov 16, 2020 0 A new temporary guidance for drug and biologics manufacturers from the U.S. Food and Drug Administration (FDA) details…